In addition, the reported accumulation of IAPP oligomers in the cerebrovasculature and brain gray matter may lead to pathological effects including prevention of Aβ clearance which contribute to AD pathology (Jackson et al., 2013). This evidence concerns the gene IAPP and Alzheimer disease.